XML 69 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Share-Based Compensation (income) expense

The following table summarizes share-based compensation (income) expense:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Performance unit incentive plan (“PUP”)

 

$

(2,187

)

 

$

3,990

 

 

$

2,260

 

Restricted stock awards and restricted stock units

 

 

4,523

 

 

 

3,200

 

 

 

2,610

 

Stock options

 

 

317

 

 

 

 

 

 

 

Share-based compensation expense before income tax

 

 

2,653

 

 

 

7,190

 

 

 

4,870

 

Income tax benefit(1)

 

 

 

 

 

(2,241

)

 

 

(1,227

)

Share-based compensation expense, net of income tax

 

$

2,653

 

 

$

4,949

 

 

$

3,643

 

(1)

There was no income tax benefit for the year ended 2020 due to the valuation allowance on our deferred tax assets. Refer to Note 17 – Income Taxes.

Summary of Activity of the Outstanding PUP Awards

The following table summarizes the activity of the outstanding PUP awards:

 

 

Equity-Based

PUP Awards

 

 

Liability-Based

PUP Awards

 

 

 

Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

 

Shares

 

 

Weighted-Average

Grant Date

Fair Value

 

Balance at December 31, 2019

 

 

59,714

 

 

$

55.10

 

 

 

155,190

 

 

$

52.53

 

Granted

 

 

32,367

 

 

$

56.23

 

 

 

52,531

 

 

$

56.10

 

Vested

 

 

 

 

$

 

 

 

(67,866

)

 

$

47.43

 

Forfeited

 

 

(30,873

)

 

$

52.15

 

 

 

(18,370

)

 

$

56.40

 

Balance at December 31, 2020

 

 

61,208

 

 

$

57.18

 

 

 

121,485

 

 

$

56.34

 

Summary of Stock Option Activity

The following table summarizes stock option activity:

 

 

Shares

 

 

Weighted-Average

Exercise Price

 

 

Aggregate Intrinsic Value(1)

 

Options outstanding and exercisable at December 31, 2019

 

 

41,143

 

 

$

16.62

 

 

 

 

 

Granted

 

 

204,150

 

 

$

19.98

 

 

 

 

 

Exercised

 

 

(41,143

)

 

$

16.62

 

 

 

 

 

Options outstanding at December 31, 2020

 

 

204,150

 

 

$

19.98

 

 

$

3,305,928

 

Options exercisable at December 31, 2020

 

 

 

 

$

 

 

$

 

(1)

The aggregate intrinsic value of stock options outstanding represents the difference between our closing stock price at the end of the reporting period and the exercise price, multiplied by the number of in-the-money stock options.  

Summary of Options Outstanding and Exercisable

The following table summarizes stock options outstanding and exercisable as of December 31, 2020:

 

 

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of exercise prices

 

 

Shares

 

 

Weighted-Average

Remaining Contractual Life

(in years)

 

 

Weighted-Average

Exercise Price

 

 

Shares

 

 

Weighted-Average

Exercise Price

 

$

19.30

 

 

 

150,000

 

 

 

8.00

 

 

$

19.30

 

 

 

 

 

$

 

$

21.85

 

 

 

54,150

 

 

 

6.65

 

 

$

21.85

 

 

 

 

 

$

 

$19.30 - $21.85

 

 

 

204,150

 

 

 

7.64

 

 

$

19.98

 

 

 

 

 

$

 

Assumptions Used in the Black-Scholes Option Pricing Model to Estimate the Fair Value of Each Stock Option Grant

Following is additional information on stock options and the underlying assumptions used in assessing fair value:

 

 

Year Ended

 

 

 

December 31, 2020

 

Assumptions used to estimate fair value of stock options granted:

 

 

 

 

Risk-free interest rate

 

0.27% - 0.31%

 

Expected life

 

4.3 - 5.4 years

 

Expected volatility

 

46.9% - 52.2%

 

Expected dividend yield

 

 

 

Weighted average grant-date fair value per share of options granted

 

$

8.38

 

Cash received from exercise of options (in thousands)

 

$

2,077